Skip to main content

Table 3 Multivariate Cox regression analysis of risk factors affecting the survival time of MM patients

From: PKP/PVP combine chemotherapy in the treatment of multiple myeloma patients with vertebral pathological fractures: minimum 3-year follow-up of 108 cases

Characteristic

P-value

HR

95% CI

Age

0.156

1.020

0.992–1.049

Gender

0.142

0.669

0.391–1.145

ISS staging

 I

0.000

0.164

0.068–0.397

 II

0.000

0.314

0.166–0.593

 III

1

Fracture location

 Thoracic vertebra

0.515

1.280

0.609–2.690

 Lumbar vertebra

0.661

1.194

0.541–2.634

 Short-segment

1

Fracture quantity

 1

0.981

1.008

0.505–2.014

 2

0.900

1.043

0.539–2.020

 ≥3

1

Stem cell transplantation

0.771

0.914

0.499–1.674

Activity disorder

0.505

0.797

0.410–1.553

Surgery

0.595

0.863

0.500–1.488